In the last 12 months, insiders at Monte Rosa Therapeutics, Inc. ($GLUE) filed 86 transactions with the SEC: 1 open-market purchases totaling $58,383 and 24 sales totaling $13,537,118. Net insider sentiment: net selling.
Monte Rosa Therapeutics, Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Versant Venture Capital VI, L.P. (Not found) — 17 transactions totaling $12,291,035
- Dunn Edmund (Principal Accounting Officer) — 15 transactions totaling $847,998
- Warmuth Markus (President & CEO) — 10 transactions totaling $380,095
- Janku Filip (Chief Medical Officer) — 8 transactions totaling $227,022
- Leo Chandra P. (Not found) — 1 transaction totaling $58,383
View all SEC Filings for Monte Rosa Therapeutics, Inc. (GLUE).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | Dunn Edmund | Principal Accounting Officer | S | Common Stock | 139 | $17.96 | 22,554.0000 | 82,942,723 | 0.61% | 0.00% |
| March 2, 2026 | Warmuth Markus | President & CEO | S | Common Stock | 5466 | $17.92 | 613,471.0000 | 82,942,723 | 0.88% | 0.01% |
| March 2, 2026 | Dunn Edmund | Principal Accounting Officer | M | Stock Option (Right to Buy) | 536 | $0.00 | 0.0000 | 82,942,723 | 100.00% | 0.00% |
| Feb. 27, 2026 | Dunn Edmund | Principal Accounting Officer | S | Common Stock | 25164 | $18.10 | 22,693.0000 | 82,942,723 | 52.58% | 0.03% |
| March 2, 2026 | Dunn Edmund | Principal Accounting Officer | M | Common Stock | 536 | $13.41 | 23,229.0000 | 82,942,723 | 2.36% | 0.00% |
| March 2, 2026 | Dunn Edmund | Principal Accounting Officer | S | Common Stock | 536 | $17.50 | 22,693.0000 | 82,942,723 | 2.31% | 0.00% |
| Feb. 27, 2026 | Dunn Edmund | Principal Accounting Officer | M | Stock Option (Right to Buy) | 25164 | $0.00 | 536.0000 | 82,942,723 | 97.91% | 0.03% |
| Feb. 27, 2026 | Dunn Edmund | Principal Accounting Officer | M | Common Stock | 25164 | $13.41 | 47,857.0000 | 82,942,723 | 110.89% | 0.03% |
| Feb. 23, 2026 | Janku Filip | Chief Medical Officer | S | Common Stock | 9189 | $19.50 | 65,837.0000 | 82,942,723 | 12.25% | 0.01% |
| Jan. 7, 2026 | Warmuth Markus | President & CEO | S | Common Stock | 1450 | $23.88 | 619,246.0000 | 82,942,723 | 0.23% | 0.00% |
| Jan. 7, 2026 | Warmuth Markus | President & CEO | S | Common Stock | 3707 | $23.24 | 620,696.0000 | 82,942,723 | 0.59% | 0.00% |
| Jan. 7, 2026 | Warmuth Markus | President & CEO | S | Common Stock | 309 | $24.57 | 618,937.0000 | 82,942,723 | 0.05% | 0.00% |
| Jan. 5, 2026 | Janku Filip | Chief Medical Officer | S | Common Stock | 3155 | $15.17 | 75,026.0000 | 82,942,723 | 4.04% | 0.00% |
| Jan. 2, 2026 | Janku Filip | Chief Medical Officer | A | Common Stock | 31000 | $0.00 | 78,181.0000 | 82,942,723 | 65.70% | 0.04% |
| Jan. 2, 2026 | Warmuth Markus | President & CEO | A | Stock Option (Right to Buy) | 406000 | $0.00 | 406,000.0000 | 82,942,723 | 9999.99% | 0.49% |
| Jan. 5, 2026 | Warmuth Markus | President & CEO | S | Common Stock | 10135 | $15.17 | 624,403.0000 | 82,942,723 | 1.60% | 0.01% |
| Jan. 2, 2026 | Warmuth Markus | President & CEO | A | Common Stock | 90000 | $0.00 | 634,538.0000 | 82,942,723 | 16.53% | 0.11% |
| Jan. 5, 2026 | Dunn Edmund | Principal Accounting Officer | S | Common Stock | 1039 | $15.17 | 22,693.0000 | 82,942,723 | 4.38% | 0.00% |
| Jan. 2, 2026 | Champoux Jennifer | Chief Operating Officer | A | Stock Option (Right to Buy) | 158000 | $0.00 | 158,000.0000 | 82,942,723 | 9999.99% | 0.19% |
| Jan. 5, 2026 | Champoux Jennifer | Chief Operating Officer | S | Common Stock | 2629 | $15.17 | 62,371.0000 | 82,942,723 | 4.04% | 0.00% |
| Jan. 2, 2026 | Champoux Jennifer | Chief Operating Officer | A | Common Stock | 35000 | $0.00 | 65,000.0000 | 82,942,723 | 116.67% | 0.04% |
| Jan. 2, 2026 | Nickson Philip | Chief Business & Legal Officer | A | Stock Option (Right to Buy) | 126000 | $0.00 | 126,000.0000 | 82,942,723 | 9999.99% | 0.15% |
| Jan. 5, 2026 | Nickson Philip | Chief Business & Legal Officer | S | Common Stock | 3155 | $15.17 | 60,845.0000 | 82,942,723 | 4.93% | 0.00% |
| Jan. 2, 2026 | Nickson Philip | Chief Business & Legal Officer | A | Common Stock | 28000 | $0.00 | 64,000.0000 | 82,942,723 | 77.78% | 0.03% |
| Jan. 2, 2026 | Townson Sharon | Chief Scientific Officer | A | Stock Option (Right to Buy) | 158000 | $0.00 | 158,000.0000 | 82,942,723 | 9999.99% | 0.19% |
| Jan. 5, 2026 | Townson Sharon | Chief Scientific Officer | S | Common Stock | 3155 | $15.17 | 67,845.0000 | 82,942,723 | 4.44% | 0.00% |
| Jan. 2, 2026 | Townson Sharon | Chief Scientific Officer | A | Common Stock | 35000 | $0.00 | 71,000.0000 | 82,942,723 | 97.22% | 0.04% |
| Jan. 2, 2026 | Janku Filip | Chief Medical Officer | A | Stock Option (Right to Buy) | 139000 | $0.00 | 139,000.0000 | 82,942,723 | 9999.99% | 0.17% |
| June 13, 2025 | Hughes Eric A | Not found | A | Stock Option (Right to Buy) | 30700 | $0.00 | 30,700.0000 | 73,910,026 | 9999.99% | 0.04% |
| June 13, 2025 | Blackwell Kimberly | Not found | A | Stock Option (Right to Buy) | 30700 | $0.00 | 30,700.0000 | 73,910,026 | 9999.99% | 0.04% |
| June 13, 2025 | Manning Anthony M. | Not found | A | Stock Option (Right to Buy) | 30700 | $0.00 | 30,700.0000 | 73,910,026 | 9999.99% | 0.04% |
| June 13, 2025 | SCHIFF ANDREW N | Not found | A | Stock Option (Right to Buy) | 30700 | $0.00 | 30,700.0000 | 73,910,026 | 9999.99% | 0.04% |
| June 13, 2025 | Skvarka Jan | Not found | A | Stock Option (Right to Buy) | 30700 | $0.00 | 30,700.0000 | 73,910,026 | 9999.99% | 0.04% |
| June 13, 2025 | Siu Christine | Not found | A | Stock Option (Right to Buy) | 30700 | $0.00 | 30,700.0000 | 73,910,026 | 9999.99% | 0.04% |
| June 13, 2025 | Behbahani Ali | Not found | A | Stock Option (Right to Buy) | 30700 | $0.00 | 30,700.0000 | 73,910,026 | 9999.99% | 0.04% |
| June 3, 2025 | Dunn Edmund | Principal Accounting Officer | S | Common Stock | 2062 | $4.45 | 23,732.0000 | 73,910,026 | 7.99% | 0.00% |
| March 24, 2025 | Leo Chandra P. | Not found | P | Common Stock | 10000 | $5.84 | 10,000.0000 | 73,910,026 | 9999.99% | 0.01% |
| Jan. 2, 2025 | Townson Sharon | Chief Scientific Officer | A | Stock Option (Right to Buy) | 161000 | $0.00 | 161,000.0000 | 73,910,026 | 9999.99% | 0.22% |
| Jan. 2, 2025 | Nickson Philip | Chief Business & Legal Officer | A | Common Stock | 36000 | $0.00 | 36,000.0000 | 73,910,026 | 9999.99% | 0.05% |
| Jan. 2, 2025 | Nickson Philip | Chief Business & Legal Officer | A | Stock Option (Right to Buy) | 161000 | $0.00 | 161,000.0000 | 73,910,026 | 9999.99% | 0.22% |
| Jan. 2, 2025 | Dunn Edmund | Principal Accounting Officer | A | Common Stock | 11850 | $0.00 | 25,794.0000 | 73,910,026 | 84.98% | 0.02% |
| Jan. 2, 2025 | Dunn Edmund | Principal Accounting Officer | A | Stock Option (Right to Buy) | 53400 | $0.00 | 53,400.0000 | 73,910,026 | 9999.99% | 0.07% |
| Jan. 2, 2025 | Janku Filip | Chief Medical Officer | A | Common Stock | 36000 | $0.00 | 45,189.0000 | 73,910,026 | 391.77% | 0.05% |
| Jan. 2, 2025 | Janku Filip | Chief Medical Officer | A | Stock Option (Right to Buy) | 161000 | $0.00 | 161,000.0000 | 73,910,026 | 9999.99% | 0.22% |
| Jan. 2, 2025 | Champoux Jennifer | Chief Operating Officer | A | Common Stock | 30000 | $0.00 | 30,000.0000 | 73,910,026 | 9999.99% | 0.04% |
| Jan. 2, 2025 | Champoux Jennifer | Chief Operating Officer | A | Stock Option (Right to Buy) | 135000 | $0.00 | 135,000.0000 | 73,910,026 | 9999.99% | 0.18% |
| Jan. 2, 2025 | Warmuth Markus | President & CEO | A | Common Stock | 128000 | $0.00 | 544,538.0000 | 73,910,026 | 30.73% | 0.17% |
| Jan. 2, 2025 | Warmuth Markus | President & CEO | A | Stock Option (Right to Buy) | 575000 | $0.00 | 575,000.0000 | 73,910,026 | 9999.99% | 0.78% |
| Jan. 2, 2025 | Townson Sharon | Chief Scientific Officer | A | Common Stock | 36000 | $0.00 | 36,000.0000 | 73,910,026 | 9999.99% | 0.05% |
| Dec. 11, 2024 | Hughes Eric A | Not found | A | Stock Option (Right to Buy) | 44200 | $0.00 | 44,200.0000 | 82,011,670 | 9999.99% | 0.05% |
| Oct. 28, 2024 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 89990 | $9.66 | 6,087,417.0000 | 82,011,670 | 1.46% | 0.11% |
| Oct. 28, 2024 | Versant Venture Capital VI, L.P. | Not found | J | Common Stock | 1019867 | $0.00 | 5,652,922.0000 | 82,011,670 | 15.28% | 1.24% |
| Oct. 28, 2024 | Versant Venture Capital VI, L.P. | Not found | J | Common Stock | 20397 | $0.00 | 4,099,866.0000 | 82,011,670 | 0.50% | 0.02% |
| Oct. 28, 2024 | Versant Venture Capital VI, L.P. | Not found | J | Common Stock | 20397 | $0.00 | 4,079,469.0000 | 82,011,670 | 0.50% | 0.02% |
| Oct. 28, 2024 | Versant Venture Capital VI, L.P. | Not found | J | Common Stock | 17595 | $0.00 | 4,097,064.0000 | 82,011,670 | 0.43% | 0.02% |
| Oct. 28, 2024 | Versant Venture Capital VI, L.P. | Not found | J | Common Stock | 17595 | $0.00 | 4,079,469.0000 | 82,011,670 | 0.43% | 0.02% |
| Oct. 28, 2024 | Versant Venture Capital VI, L.P. | Not found | J | Common Stock | 366590 | $0.00 | 5,720,827.0000 | 82,011,670 | 6.02% | 0.45% |
| Oct. 28, 2024 | Versant Venture Capital VI, L.P. | Not found | J | Common Stock | 5499 | $0.00 | 4,084,968.0000 | 82,011,670 | 0.13% | 0.01% |
| Oct. 28, 2024 | Versant Venture Capital VI, L.P. | Not found | J | Common Stock | 5499 | $0.00 | 4,079,469.0000 | 82,011,670 | 0.13% | 0.01% |
| Oct. 28, 2024 | Versant Venture Capital VI, L.P. | Not found | J | Common Stock | 5454 | $0.00 | 4,084,923.0000 | 82,011,670 | 0.13% | 0.01% |
| Oct. 28, 2024 | Versant Venture Capital VI, L.P. | Not found | J | Common Stock | 5454 | $0.00 | 4,079,469.0000 | 82,011,670 | 0.13% | 0.01% |
| Oct. 29, 2024 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 52305 | $9.08 | 5,668,522.0000 | 82,011,670 | 0.91% | 0.06% |
| Oct. 29, 2024 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 15600 | $9.41 | 5,652,922.0000 | 82,011,670 | 0.28% | 0.02% |
| Sept. 20, 2024 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 1132566 | $6.53 | 7,197,274.0000 | 51,396,961 | 13.60% | 2.20% |
| Sept. 13, 2024 | Janku Filip | Chief Medical Officer | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 51,396,961 | 9999.99% | 0.06% |
| Sept. 13, 2024 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 9269 | $6.16 | 8,329,840.0000 | 51,396,961 | 0.11% | 0.02% |
| Sept. 12, 2024 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 16047 | $6.00 | 8,339,109.0000 | 51,396,961 | 0.19% | 0.03% |
| Sept. 11, 2024 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 541897 | $6.00 | 8,355,156.0000 | 51,396,961 | 6.09% | 1.05% |
| July 5, 2024 | Dunn Edmund | Principal Accounting Officer | S | Common Stock | 1610 | $3.83 | 13,944.0000 | 51,396,961 | 10.35% | 0.00% |
| June 12, 2024 | SCHIFF ANDREW N | Not found | A | Stock Option (Right to Buy) | 22100 | $0.00 | 22,100.0000 | 51,396,961 | 9999.99% | 0.04% |
| June 12, 2024 | Blackwell Kimberly | Not found | A | Stock Option (Right to Buy) | 22100 | $0.00 | 22,100.0000 | 51,396,961 | 9999.99% | 0.04% |
| June 12, 2024 | Siu Christine | Not found | A | Stock Option (Right to Buy) | 22100 | $0.00 | 22,100.0000 | 51,396,961 | 9999.99% | 0.04% |
| June 12, 2024 | Skvarka Jan | Not found | A | Stock Option (Right to Buy) | 22100 | $0.00 | 22,100.0000 | 51,396,961 | 9999.99% | 0.04% |
| June 12, 2024 | Manning Anthony M. | Not found | A | Stock Option (Right to Buy) | 22100 | $0.00 | 22,100.0000 | 51,396,961 | 9999.99% | 0.04% |
| June 12, 2024 | Behbahani Ali | Not found | A | Stock Option (Right to Buy) | 22100 | $0.00 | 22,100.0000 | 51,396,961 | 9999.99% | 0.04% |
| June 3, 2024 | Townson Sharon | Chief Scientific Officer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 51,396,961 | 9999.99% | 0.08% |
| June 3, 2024 | Champoux Jennifer | Chief Operating Officer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 51,396,961 | 9999.99% | 0.08% |
| June 3, 2024 | Dunn Edmund | Principal Accounting Officer | S | Common Stock | 1207 | $4.04 | 15,554.0000 | 51,396,961 | 7.20% | 0.00% |
| June 3, 2024 | Nickson Philip | Chief Business & Legal Officer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 51,396,961 | 9999.99% | 0.08% |
| Jan. 2, 2024 | Dunn Edmund | Principal Accounting Officer | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 51,396,961 | 9999.99% | 0.05% |
| Jan. 2, 2024 | Nickson Philip | General Counsel | A | Stock Option (Right to Buy) | 109000 | $0.00 | 109,000.0000 | 51,396,961 | 9999.99% | 0.21% |
| Jan. 2, 2024 | Janku Filip | Chief Medical Officer | A | Stock Option (Right to Buy) | 121000 | $0.00 | 121,000.0000 | 51,396,961 | 9999.99% | 0.24% |
| Jan. 2, 2024 | Jones Jullian G | Chief Business Officer | A | Stock Option (Right to Buy) | 79000 | $0.00 | 79,000.0000 | 51,396,961 | 9999.99% | 0.15% |
| Jan. 2, 2024 | Dunn Edmund | Principal Accounting Officer | A | Stock Option (Right to Buy) | 35900 | $0.00 | 35,900.0000 | 51,396,961 | 9999.99% | 0.07% |
| Jan. 2, 2024 | Warmuth Markus | President & CEO | A | Stock Option (Right to Buy) | 346000 | $0.00 | 346,000.0000 | 51,396,961 | 9999.99% | 0.67% |
| Jan. 2, 2024 | Wallace Owen B. | Chief Scientific Officer | A | Stock Option (Right to Buy) | 119000 | $0.00 | 119,000.0000 | 51,396,961 | 9999.99% | 0.23% |